A Comparative Study of Adding Ipratropium to Salbutamol for the Treatment of Asthma Attack in Children

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

June 30, 2024

Study Completion Date

July 15, 2024

Conditions
Asthma ExacerbationChildren
Interventions
DRUG

Salbutamol (Ventolin®)

Children were given 0.5% salbutamol aerosol solution (0.15 mg/kg weight, up to a maximum of 5 mg) in 5mL of normal saline solution for 7 min every 20 min for 2 h, and then every 30 min for two more hours. Aerosol were generated by nebulizer powered by compressed-air (5 L/min) with Y-connection with oxygen (3 L/min) and delivered via a face mask.

DRUG

salbutamol + ipratropium bromide nebules

In addition to Salbutamol nebulization, children received ipratropium bromide nebulization. Ipratropium bromide solution (250 mcg in children \<20 kg weight or 500 mcg in children \>=20 kg) every 20 min for the first 2 hours then every 30 min for 2 hours more will be given in between the salbutamol nebulization. Aerosol were generated by nebulizer powered by compressed-air (5 L/min) with Y-connection with oxygen (3 L/min) and delivered via a face mask.

Trial Locations (1)

60000

Children's Hospital and Institute of Child Health, Multan

All Listed Sponsors
lead

Children's Hospital and Institute of Child Health, Multan

OTHER_GOV

NCT06918418 - A Comparative Study of Adding Ipratropium to Salbutamol for the Treatment of Asthma Attack in Children | Biotech Hunter | Biotech Hunter